Table 1 Baseline characteristics in the overall population, and in patients without diabetes mellitus and not receiving statins
From: C-reactive protein levels in patients at cardiovascular risk: EURIKA study
Overall | Patients without diabetes mellitus who were not receiving statin treatment | Patients at intermediate riskaand not receiving statin treatment | |
|---|---|---|---|
(N = 7565) | (n = 3434) | (n = 1573) | |
Age, years | 63.2 (9.0) | 61.9 (9.2) | 58.2 (5.6) |
Women, n (%) | 3903 (51.6) | 1872 (54.5) | 909 (57.8) |
Dyslipidaemia, n (%) | 4372 (57.8) | 879 (25.6) | 439 (27.9) |
Total cholesterol, mmol/L | 5.5 (1.1) | 5.8 (1.0) | 5.8 (1.0) |
LDL-C, mmol/L | 3.2 (1.0) | 3.6 (0.9) | 3.6 (0.9) |
HDL-C, mmol/L | 1.4 (0.4) | 1.5 (0.4) | 1.5 (0.4) |
Triglycerides, mmol/L | 1.8 (1.3) | 1.7 (1.2) | 1.7 (1.0) |
Hypertension, n (%) | 5496 (72.7) | 2471 (72.0) | 1076 (68.4) |
SBP, mmHg | 135.0 (16.6) | 135.5 (16.8) | 132.4 (14.6) |
DBP, mmHg | 80.9 (9.9) | 82.1 (10.1) | 82.0 (9.6) |
Diabetes mellitus, n (%) | 2027 (26.8) | 0 (0.0) | 0 (0.0) |
BMI, kg/m2 | 28.9 (5.4) | 28.4 (5.4) | 28.8 (5.5) |
Obese, n (%) | 3288 (43.5) | 1357 (39.5) | 677 (43.0) |
Current smoker, n (%)b | 1594 (21.3) | 862 (25.5) | 423 (26.9) |
CRP, mg/L | 4.2 (8.7) | 4.3 (8.4) | 4.2 (7.5) |